Insider Shareholders with Direct Ownership of Aldeyra Therapeutics, Inc. (ALDX)
This section provides a comprehensive overview of the insiders with direct ownership of Aldeyra Therapeutics, Inc. (ALDX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Aldeyra Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Todd C Brady
President and CEO |
826,127 | 257,045 | 1,471,298 $7.18 Million | 8 |
Mar 12, 2024
Reduced 5.48%
|
|
Joshua Reed
Chief Financial Officer |
93,322 | 0 | 274,825 $1.34 Million | 1 |
Mar 30, 2022
Added 25.35%
|
|
Stephen Machatha
Chief Development Officer |
250,000 | 45,809 | 236,771 $1.16 Million | 5 |
Aug 12, 2024
Reduced 6.35%
|
| 126,087 | 24,035 | 126,382 $616,744 | 3 |
Aug 12, 2024
Reduced 7.9%
|
|
| 9,604 | 0 | 28,248 $137,850 | 1 |
Jun 27, 2023
Added 25.37%
|
|
| 4,323 | 0 | 23,967 $116,958 | 1 |
Jun 23, 2022
Added 15.28%
|
|
| 9,604 | 0 | 15,854 $77,367 | 1 |
Aug 22, 2023
Added 37.72%
|
|
| 5,437 | 0 | 14,812 $72,282 | 1 |
Sep 07, 2023
Added 26.85%
|
|
| 922 | 0 | 922 $4,499 | 2 |
Apr 12, 2023
Added 35.57%
|